Trials / NCT06545253
A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants
Not yet recruiting Observational Natural history / observational
- Sponsor
- IRCCS Ospedale San Raffaele
- Treatment
- microRNAs analysis
- Gene
- USH2A
- Conditions
- USH2A Variant Retinitis Pigmentosa
- Ages
- 18 Years to no upper limit
- Enrollment
- 60 participants
- Started
- 2024-08
- Main results expected
- 2025-02
- Results posted
- Not yet
- Record last updated
- 2024-08-09
What the study is testing
Aim of the study is to perform a non-invasive multimodal retinal imaging investigation in a cohort of patients affected by USH2A retinitis pigmentosa (USH2A-RP), in order to develop a new diagnostic paradigm to categorize clinically relevant subgroups. All the procedures will be performed according to normal clinical practice. In addition, a novel quantitative profiling of serum microRNAs will be carried out in order to analyze the clinical importance of microRNA biomarkers in the clinical setting of the disease.
Where it runs
No sites listed yet.